Boxer Michael A's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Jul 29, 2024
- Accession no.
- 0001127602-24-021118
- Filed
- Jul 29, 2024
- Trade date
- Jul 26, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.20M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boxer Michael ACIK 0001726596 | Officer (SVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 26, 2024 | Common Stock | MOption exerciseAcquired | +2,000 | $210.68 | +$421,360 | 15,083.17 | Direct | |
| Jul 26, 2024 | Common Stock | SSaleDisposed | −2,000 | $600.85 | −$1,201,700 | 13,083.17 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 26, 2024 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 2,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.